Ibex Investors LLC Geron Corp Transaction History

Ibex Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 07, 2019	SELL	$1.01 - $1.83 $209,130 - $378,919	-207,060 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$0.98 - $1.85 $202,918 - $383,061	207,060 New	207,060 $207,000
Q2 2018 Aug 14, 2018	SELL	$3.29 - $4.82 $186,819 - $273,698	-56,784 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.81 - $5.98 $102,779 - $339,568	56,784 New	56,784 $241,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.14B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Ibex Investors LLC with notifications on news.